[go: up one dir, main page]

DE60105618D1 - Dihydroporphyrinderivate und ihre verwendung - Google Patents

Dihydroporphyrinderivate und ihre verwendung

Info

Publication number
DE60105618D1
DE60105618D1 DE60105618T DE60105618T DE60105618D1 DE 60105618 D1 DE60105618 D1 DE 60105618D1 DE 60105618 T DE60105618 T DE 60105618T DE 60105618 T DE60105618 T DE 60105618T DE 60105618 D1 DE60105618 D1 DE 60105618D1
Authority
DE
Germany
Prior art keywords
dihydroporphyrine
derivatives
dihydroporphyrin
photochemotherapy
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60105618T
Other languages
English (en)
Inventor
Ludovic Bourre
Thierry Patrice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANULM ASS NATAISE POUR L UTILI
Original Assignee
ANULM ASS NATAISE POUR L UTILI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANULM ASS NATAISE POUR L UTILI filed Critical ANULM ASS NATAISE POUR L UTILI
Application granted granted Critical
Publication of DE60105618D1 publication Critical patent/DE60105618D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036Porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60105618T 2000-08-01 2001-07-27 Dihydroporphyrinderivate und ihre verwendung Expired - Lifetime DE60105618D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010165A FR2812637B1 (fr) 2000-08-01 2000-08-01 Nouveaux composes derives de dihydroporphyrine et leurs applications
PCT/FR2001/002470 WO2002010173A1 (fr) 2000-08-01 2001-07-27 Derives de dihydroporphyrine et leurs applications

Publications (1)

Publication Number Publication Date
DE60105618D1 true DE60105618D1 (de) 2004-10-21

Family

ID=8853209

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60105618T Expired - Lifetime DE60105618D1 (de) 2000-08-01 2001-07-27 Dihydroporphyrinderivate und ihre verwendung

Country Status (11)

Country Link
US (1) US20040022734A1 (de)
EP (1) EP1305317B1 (de)
JP (1) JP2004512270A (de)
AT (1) ATE276259T1 (de)
AU (1) AU2001282238A1 (de)
CA (1) CA2416523A1 (de)
DE (1) DE60105618D1 (de)
FR (1) FR2812637B1 (de)
NO (1) NO20030500D0 (de)
NZ (1) NZ523765A (de)
WO (1) WO2002010173A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20020200A1 (it) 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
EP3459955B1 (de) * 2008-09-18 2022-11-02 biolitec Unternehmensberatungs II AG Neues verfahren und anwendung unsymmetrisch meso-substituierter porphyrine und chlorine für die pdt
CN114213258B (zh) * 2021-12-13 2024-06-18 北京未名元上分子技术有限公司 一种平面共轭分子化合物及包含其的单分子场效应晶体管

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236915A (en) * 1990-05-31 1993-08-17 Health Research, Inc. Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents

Also Published As

Publication number Publication date
NO20030500L (no) 2003-01-31
EP1305317A1 (de) 2003-05-02
AU2001282238A1 (en) 2002-02-13
NO20030500D0 (no) 2003-01-31
FR2812637A1 (fr) 2002-02-08
EP1305317B1 (de) 2004-09-15
NZ523765A (en) 2004-11-26
JP2004512270A (ja) 2004-04-22
CA2416523A1 (fr) 2002-02-07
US20040022734A1 (en) 2004-02-05
ATE276259T1 (de) 2004-10-15
WO2002010173A1 (fr) 2002-02-07
FR2812637B1 (fr) 2002-10-25

Similar Documents

Publication Publication Date Title
NO20041493L (no) Kjemiske forbindelser.
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
ATE318267T1 (de) Einige alkylendiamin-substituierte heterocyclen
EA200500017A1 (ru) Новые соединения
NO20044995L (no) Heterosykliske forbindelser
DK1200418T3 (da) Nematodicide trifluorbutener
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
ATE484508T1 (de) Furylverbindungen
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE411287T1 (de) Neue metallproteinaseinhibitoren
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
ATE399168T1 (de) Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
SE0002739D0 (sv) New use
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
ATE374751T1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer
ATE334977T1 (de) Discodermolid-analoga und ihre pharmazeutische verwendung
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
DE602004002464D1 (de) IMIDAZOi4,5-BöCHINOLINDERIVATE UND IHRE VERWENDUNG ALS INHIBITOREN DER INDUZIERBAREN NO-SYNTHASE

Legal Events

Date Code Title Description
8332 No legal effect for de